跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROPIVACAINE HYDROCHLORIDE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Authorized
STANDARD
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a1b2a8dc3ec2f424
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
a1b2a8dc3ec2f424
Drug Approval Canada Name
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Product Name
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Status
Marketed
Status Date
2019-02-26
Original Market Date
2019-02-26
Din
02439409
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Epidural
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB09 ROPIVACAINE
Atc Name
n 01 bb 09
Aig Number
0133273005
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ROPIVACAINE HYDROCHLORIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a1b2a8dc3ec2f424
Type
Standard
Back to Health Canada Approvals